Archived - Awareness of Hep C among health care providers


Published by: The Public Health Agency of Canada
Issue: Volume 44-7/8 : Can we eliminate hepatitis C?
Date published: July 5, 2018
ISSN: 1481-8531
Submit a manuscript
About CCDR
Browse
Volume 44-7/8, July 5, 2018: Can we eliminate hepatitis C?
Scoping review
Awareness and knowledge of hepatitis C among health care providers and the public: A scoping review
S Ha1, K Timmerman1
Affiliation
1 Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON
Correspondence
Suggested citation
Ha S, Timmerman K. Awareness and knowledge of hepatitis C among health care providers and the public: A scoping review. Can Commun Dis Rep 2018;44(7/8):157-65. https://doi.org/10.14745/ccdr.v44i78a02
Keywords: awareness, knowledge, hepatitis C, scoping review, health care providers
Abstract
Background: The Global Viral Hepatitis Strategy aims to eliminate hepatitis as a public health threat by 2030. The hepatitis C virus (HCV) can be difficult to detect as infection can remain asymptomatic for decades. Individuals are often neither offered nor seek testing until symptoms develop. This highlights the importance of increasing awareness and knowledge among health care providers and the public to reach the viral hepatitis goals.
Objectives: To conduct a scoping review to characterize current awareness and knowledge among health care providers and the public regarding HCV infection, transmission, prevention and treatment and to identify knowledge gaps that public health action could address.
Methods: A literature search was conducted using Embase, Medline and Scopus to find studies published between January 2012 and July 2017. A search for grey literature was also undertaken. The following data were extracted: author, year of publication, study design, population, setting, country, method of data collection, and knowledge and awareness outcomes. Commentaries, letters to the editor and narrative reviews were excluded.
Results: Nineteen studies were included in this review. The definition of awareness and knowledge varied across studies; at times, these terms were used interchangeably. Health care providers identified injection drug use or blood transfusions as routes of HCV transmission more frequently than other routes of transmission such as tattooing with unsterile equipment and sexual transmission. Among the general public, misconceptions about HCV included believing that kissing and casual contact were routes of HCV transmission and that a vaccine to prevent HCV was available. Overall, there was a lack of data on other high-risk populations (e.g., Indigenous, incarcerated).
Conclusion: Continued public and professional education campaigns about HCV could help support HCV risk-based screening and testing. Future research could assess the awareness of other populations at increased risk and include consistent definitions of awareness and knowledge.
Background
Hepatitis C virus (HCV) causes inflammation of the liver, which can become chronic. Chronic HCV infection can be asymptomatic for decades before symptoms appear. Globally, about 71 million people have chronic HCV infectionFootnote 1. Chronic HCV infection is not easy to detect; even when symptoms are present, they are often nonspecific (e.g., fatigue)Footnote 2. Chronic HCV infection can lead to cirrhosis or liver cancer. Approximately half a million people die each year from HCV-related liver diseasesFootnote 3.
In 2011, about 220,000-246,000 individuals were living with chronic HCV infection in Canada and approximately 44% were unaware of their infectionFootnote 4. Over the past few years, there have been significant advances in HCV treatment, and infection is now curable. Previous treatment regimens consisted of peg-interferon and ribavirin, which involved longer treatment durations and more side effects. The new interferon-free direct acting antiviral (DAA) treatments have been found to be highly effective and have fewer side effects. Currently, most provincial and territorial formularies cover these new treatments and Canada has started to witness a decrease in hospitalizations associated with HCV infection and chronic liver diseaseFootnote 5.
In 2016, the 69th World Health Assembly adopted the Global Health Sector Strategy on Viral Hepatitis with the goal of eliminating both hepatitis B and C as a public health threat by 2030Footnote 6. The goal is to have 90% of viral hepatitis B and C diagnosed and 80% of eligible people with chronic hepatitis B virus (HBV) and chronic HCV infection treatedFootnote 6. Awareness and knowledge of hepatitis C is an important first step in the elimination strategy. The identification of HCV through screening and testing is essential for patients to make appropriate lifestyle changes and to begin treatment.
Limited awareness of and knowledge about HCV have been identified as the key barriers to health care providers offering hepatitis C testing and for patients seeking testingFootnote 7. This lack of awareness and knowledge leads to continued HCV transmission and missed prevention and treatment opportunities. In an effort to improve risk-based screening in Canada and to reduce the number of people who are unaware of their infection, it is important to understand current awareness and knowledge of HCV among health care providers and the public alike.
The objectives of this review are to summarize health care providers' and the general public's awareness and knowledge of the natural history of HCV and HCV transmission, prevention and treatment, and to identify knowledge gaps in both groups that public health action could address.
Methods
We worked with a research librarian to conduct a literature search in Embase, Medline and Scopus for published studies on awareness and knowledge of HCV among health care providers and the public. We also completed a search for grey literature (i.e., reports available on public domains) using Google. The following search terms were used: hepatitis C, HCV, awareness, and knowledge. Studies were included in the review if they were published between January 2012 and July 2017; published in English or French; conducted in Canada or similarly economically developed and well-resourced countries; and focused on the public or health care providers. We restricted the search years to the last five years to capture the most recent information. Commentaries, letters to editors and case studies were excluded. Outcomes of interest included HCV awareness and knowledge, which are defined in various ways based on the study.
After screening the titles and abstracts of potentially relevant articles, we reviewed the full texts of included studies. We developed data extraction forms and extracted data on the following: author, year of publication, study design, population, setting, country, method of data collection, and knowledge and awareness outcomes.
As a scoping review a qualitative analysis of the findings was completed and the results were summarized into themes but we did not conduct a detailed assessment of overall quality or risk of bias.
Results
The literature search identified 141 potentially relevant articles on HCV awareness and knowledge of health care providers and the general public. A manual search of the reference lists identified five additional references. An additional three reports were identified through the grey literature search. After the title and abstract screening and the full text review, 19 studies were included in this review (Figure 1).
Awareness and knowledge were at times used interchangeably in the included studies. Awareness was defined as either awareness of one's own HCV infection, diagnosis or seropositivity or awareness of the existence of HCV, the risk factors or availability of treatment. Knowledge could include the natural history and consequences of HCV, HCV risk factors and transmission routes, or vaccine and treatment availability. Consequently, the results are reported based on how the studies themselves defined awareness and knowledge.
Figure 1: Flowchart of study selection process
Text description: Figure 1
Figure 1: Flowchart of study selection process
Figure 1 depicts a flowchart of the study selection process. The top-left box indicates that 141 records were found during the database search, with an additional five studies identified through a manual search, and three identified through a grey literature search. This box leads to the total number of records (n=149).
To the right of the total box is a description of the number of records excluded and why. Of the 149 total, 130 records were excluded. The reasons for exclusion include: 1) Objective was not focused on awareness and knowledge of HCV (n=93), 2) the records did not meet the study design criteria (n=6), and 3) the records were focused on other populations (e.g., people who inject drugs, inmates, methadone maintenance patients, n=31).
The final box shows the total number of records included in this scoping review (n=19).
Characteristics of included studies
The majority of the included studies were conducted in the United States (US; n=8), followed by Canada (n=5) and Australia (n=3). The remainder of the studies were from Germany, Italy, Japan and Netherlands. Most of the studies (n=13) targeted the general population and less than one-third (n=5) focused on health care providers; one study included both populations. Participants were recruited from a variety of settings including hospitals, outpatient clinics, primary care clinics, emergency departments and online panels. Data collection methods most often included questionnaires completed online, in-person or by phone. (For more details about the included studies, please refer to Appendix 1.)
Of the studies that focused on health care providers, job categories included physicians, nurses, residents, dental students and specialists (i.e., hepatologists and gastroenterologists). Of the studies that focused on non–health care providers, population groups included HCV-infected people with or without HIV coinfection, men who have sex with men (MSM), immigrants, the general public and adults born between 1945 and 1965 (Table 1).
Characteristics | Number of studies (n)Table 1 Footnote a |
---|---|
Country | |
United States | 8 |
Canada | 5 |
Australia | 3 |
Netherlands | 2 |
Germany | 1 |
Italy | 1 |
Japan | 1 |
Other | 3 |
Health care providers | |
Physicians | 3 |
Nurses | 3 |
Specialists (e.g., hepatologist, gastroenterologist) | 2 |
Medical students | 1 |
Other | 1 |
Non–health care providers | |
People living with HCV with or without HIV coinfection | 4 |
Men who have sex with men (MSM) | 3 |
General public | 2 |
People born between 1945–1965 | 2 |
Immigrants | 1 |
Other | 1 |
Abbreviations: HCV, hepatitis C virus; HIV, human immunodeficiency virus; n, number |
Awareness
There were six studies on awareness of hepatitis CFootnote 11Footnote 12Footnote 14Footnote 17Footnote 18Footnote 24. The types of awareness varied across these studies: awareness of risk factors, of treatment, of one’s own infection and of the existence of HCV. Four studies included findings on awareness of HCV by the general publicFootnote 11Footnote 12Footnote 14Footnote 17, one on awareness of HCV by MSMFootnote 18 and one on awareness of treatment by Canadian health care providersFootnote 24.
Two studies found that the general public had some awareness (defined as the knowledge that something exists) of hepatitis CFootnote 11Footnote 17. Compared with the public (27%), Canadian-born baby boomers (33%) were more likely to be aware that injection drug users have an increased risk of HCV compared with the general public (27%)Footnote 14. However, results from the United States’ National Health and Nutrition Examination Survey (NHANES) indicated that fewer than half of Americans who had HCV infection were aware of their infectionFootnote 12. Two studies found that the general public was not clear about the differences between hepatitis A, B and CFootnote 11Footnote 19.
Knowledge
All of the included studies assessed knowledge of HCV. Knowledge was measured using a series of yes/no/don’t know or true/false statements, or one’s perceived knowledge level. Knowledge was assessed in the following topics: natural history of HCV, transmission routes, the availability of a vaccine and the availability of treatment.
The natural history of HCV and its consequences
Three studies included information on health care providers’ knowledge of the natural history and consequences of HCVFootnote 16Footnote 25Footnote 26. In a convenience study of Canadian physicians, 35% reported “knowing a lot” about symptoms associated with HCVFootnote 16. In a small study of dental students from Bulgaria, 80% reported knowing that infection with hepatitis B virus or HCV may be asymptomaticFootnote 26. In addition, residents, physicians, nurse practitioners and physician assistants working in emergency departments in the US were reported to have high knowledge scores regarding the manifestations of HCV (percentage not reported)Footnote 25.
Eight studies included information on the public’s knowledge about the natural history of HCVFootnote 8Footnote 9Footnote 11Footnote 13Footnote 14Footnote 16Footnote 17Footnote 19. Two Canadian studies found that 83–90% of participants knew that people with HCV could be unaware of an existing infectionFootnote 14Footnote 16. Similarly, over half (57%) of US baby boomers knew that HCV can lead to liver cancer and 61% believed that someone with HCV infection can present with no symptomsFootnote 8. One study reported that one-third of MSM knew that HCV infection could lead to liver cancer (31%) and liver failure (37%)Footnote 18. Conversely, in an international study with immigrants from Asia, it was reported that there was confusion about the different types of hepatitis infections and uncertainty about the natural history of the infectionFootnote 19.
Knowledge of transmission
Two studies reported on health care providers’ knowledge of HCV transmissionFootnote 22Footnote 26. The majority of health care providers in the studies identified the main routes of transmission as blood transfusions, exposure to blood during sexual activity and sharing needles while injecting drugsFootnote 22Footnote 26. A small percentage (12%) of nurses working in hemodialysis clinics in Italy believed, incorrectly, that HCV can be transmitted through kissing, and 19% did not know that getting a tattoo could be a means of HCV transmissionFootnote 22.
Ten studies reported information on knowledge of HCV transmission among the general publicFootnote 8Footnote 10Footnote 11Footnote 12Footnote 14Footnote 15Footnote 16Footnote 17Footnote 19Footnote 21. One Canadian study reported that the most frequently known HCV transmission routes were blood transfusions, unsafe/unprotected intercourse and injection drug use/sharing of needlesFootnote 14. Few Canadians identified other routes of transmission such as sharing personal hygiene items (7%), getting tattoos and body piercings (4%), exposure to risk factors while travelling in foreign countries where HCV may be endemic (4%), and mother-to-child transmission through pregnancy (1%)Footnote 14. Furthermore, approximately 54–62% of the general population in Canada knew that HCV is transmitted mainly through blood-to-blood contactFootnote 16. In four studies, a small percentage of the general public indicated that HCV can be transmitted through kissing or casual contactFootnote 8Footnote 12Footnote 14Footnote 21.
Knowledge of treatment
Two recent studies, published after the new interferon-free DAA therapies became available, focused on knowledge of the curability of HCVFootnote 8Footnote 24.
Among health care providers, specialists (i.e., hepatologists, gastroenterologists, hepatology nurses) scored higher on knowledge statements about HCV treatment than general practitioners (GPs)Footnote 23Footnote 24. Of the 10 primary care physicians surveyed, seven were unsure or not aware of the new interferon-free DAAs and were not sure about the mechanisms of actionFootnote 24.
In the US, 51% of baby boomers presenting to emergency departments correctly believed that HCV is curable and 77% had knowledge of new medications available to treat HCVFootnote 8. However, three studies detected a misconception among the general public about the availability of a vaccine to prevent HCVFootnote 11Footnote 15Footnote 21. About one half of the Canadians interviewed (50%) in one study believed there was a vaccine to prevent HCV Footnote 14. In two US studies, 42% of American baby boomers and 60% of African-American baby boomers believed there was a vaccine to prevent HCVFootnote 8Footnote 11.
A summary of the findings is shown in Table 2.
Outcomes | Key Findings |
---|---|
Awareness | Public: The general public was aware of HCV and main risk factorsFootnote 14 MSM had high awareness of HCV treatmentFootnote 18 |
Knowledge | Health care providers: Specialists were more up-to-date on new HCV treatments than primary care physiciansFootnote 24 Health care providers knew less about some routes of HCV transmission (e.g. unsafe tattooing practices or piercings) compared with the main routes (i.e., injection drug use)Footnote 22Footnote 26 |
Public: The general public had misconceptions around risk factors for transmission of hepatitis C (e.g., casual contact, saliva, kissing)Footnote 11Footnote 12Footnote 14Footnote 16Footnote 19 There were also misconceptions about the availability of a vaccineFootnote 8Footnote 14Footnote 16 Overall, there was little knowledge about the interferon-free DAA hepatitis C treatmentFootnote 8Footnote 9Footnote 13Footnote 14Footnote 16 |
|
Abbreviations: DAA, direct acting antivirals; HCV, hepatitis C virus; MSM, men who have sex with men |
Discussion
To the best of our knowledge, this is the first scoping review that provides a snapshot of what health care providers and the general public know about HCV. Overall, health care providers know about the most common transmission routes and risk factors, whereas specialists are more up-to-date on treatments than primary care physiciansFootnote 23Footnote 24. The general public is aware of HCV; however, some people do not know the difference between hepatitis A, B and C; there are misconceptions around routes of transmission; and some incorrectly believe that an HCV-preventable vaccine exists.
There are some limitations to consider when interpreting our findings. First, there was a lack of standard definitions for knowledge and awareness and the terms were often used interchangeably. Second, only a few studies captured awareness and knowledge of interferon-free DAA treatments. Finally, the findings were based on cross-sectional studies, which only capture data of a study population at a single point in time.
Future research could include assessment of high-risk populations (e.g., Indigenous peoples or incarcerated populations); incorporate clear and consistent definitions of awareness and knowledge; and assess factors that may be associated with differences in awareness and knowledge (e.g., rural versus urban settings, and socioeconomic status). Additional research on health care providers’ knowledge of HCV could also help tailor future knowledge translation and exchange products.
In conclusion, increasing health care providers’ and the general public’s awareness of and knowledge about HCV can facilitate the discussion about whether HCV testing should be considered. The findings and gaps identified in this review can help inform future interventions and public health campaigns to do with HCV and support the Global Health Sector Strategy on Viral Hepatitis.
Authors’ statement
SH – Conceptualization, methodology, writing (final draft), data curation, validation, formal analysis, writing, reviewing and editing, supervision, project administration, visualization
KT– Conceptualization, methodology, reviewing and editing, supervision, project administration, visualization
Conflict of interest
None.
Acknowledgements
We would like to thank Dr. Margaret Gale-Rowe and Dr. Jun Wu for their contributions to the conceptualization and revision of this manuscript, Audréanne Garand for her support in the data collection, extraction and initial analysis of the results, and the Health Canada librarian who helped conduct the literature search.
Funding
This work was supported by the Public Health Agency of Canada.
References
- Footnote 1
-
World Health Organization. Hepatitis C: key facts. Geneva: World Health Organization; 2017. http://www.who.int/en/news-room/fact-sheets/detail/hepatitis-c
- Footnote 2
-
Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol 2014 Nov;61(1 Suppl):S58–68. http://dx.doi.org/10.1016/j.jhep.2014.07.012.
- Footnote 3
-
World Health Organization. Global hepatitis report, 2017. Geneva: World Health Organization; 2017. http://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf?sequence=1
- Footnote 4
-
Trubnikov M, Yan P, Archibald C. Estimated prevalence of hepatitis C virus infection in Canada, 2011. Can Commun Dis Rep 2014 Dec;40(19):429–36. https://www.ncbi.nlm.nih.gov/pubmed/29769874
- Footnote 5
-
Schanzer D, Pogany L, Aho J, Tomas K, Gale-Rowe M, Kwong J, Janjua NZ, Feld J. Impact of availability of direct-acting antivirals for hepatitis C on Canadian hospitalization rates, 2012–2016. Can Commun Dis Rep 2018;44(7/8):150–6. https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-7-8-july-5-2018/article-1-canadian-hospitalization-rates-hep-c.html
- Footnote 6
-
World Health Organization. Global Health Sector Strategy on Viral Hepatitis 2016–2021: towards ending viral hepatitis. Geneva: World Health Organization; 2016. http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua=1
- Footnote 7
-
McLeod A, Cullen BL, Hutchinson SJ, Roy KM, Dillon JF, Stewart EA, Goldberg DJ. Limited impact of awareness-raising campaigns on hepatitis C testing practices among general practitioners. J Viral Hepat 2017 Nov;24(11):944–54. http://dx.doi.org/10.1111/jvh.12724
- Footnote 8
-
Allison WE, Chiang W, Rubin A, Oshva L, Carmody E. Knowledge about hepatitis C virus infection and acceptability of testing in the 1945–1965 birth cohort (baby boomers) presenting to a large urban emergency department: a pilot study. J Emerg Med 2016 Jun;50(6):825–831.e2. http://dx.doi.org/10.1016/j.jemermed.2016.02.001
- Footnote 9
-
CATIE. Room for improvement: knowledge exchange needs of people living with hepatitis C. Toronto: CATIE; 2015. http://www.catie.ca/sites/default/files/Hepatitis%20C%20needs%20assessment%20report_final.pdf
-
Chen EY, North CS, Fatunde O, Bernstein I, Salari S, Day B, Jain MK. Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults. J Viral Hepat 2013 Oct;20(10):708–14. http://dx.doi.org/10.1111/jvh.12095
- Footnote 11
-
Crutzen R, Göritz AS. Public awareness and practical knowledge regarding Hepatitis A, B, and C: a two-country survey. J Infect Public Health 2012 Apr;5(2):195–8. http://dx.doi.org/10.1016/j.jiph.2011.12.001
- Footnote 12
-
Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology 2012 Jun;55(6):1652–61. http://dx.doi.org/10.1002/hep.25556
- Footnote 13
-
Eguchi H, Wada K. Knowledge of HBV and HCV and individuals’ attitudes toward HBV- and HCV-infected colleagues: a national cross-sectional study among a working population in Japan. PLoS One 2013 Sep;8(9):e76921. http://dx.doi.org/10.1371/journal.pone.0076921
- Footnote 14
-
EKOS Research Associates Inc. 2012 HIV/AIDS attitudinal tracking survey. Ottawa: EKOS; 2012 Oct. http://www.catie.ca/sites/default/files/2012-HIV-AIDS-attitudinal-tracking-survey-final-report.pdf
- Footnote 15
-
Hopwood M, Lea T, Aggleton P. Multiple strategies are required to address the information and support needs of gay and bisexual men with hepatitis C in Australia. J Public Health (Oxf) 2016 Mar;38(1):156–62. http://dx.doi.org/10.1093/pubmed/fdv002
- Footnote 16
-
Ipsos Healthcare. Survey on hepatitis C knowledge and perception among Canadians and GP, September 2012. Paris: Ipsos; 2012. https://www.ipsos.com/sites/default/files/publication/2013–01/5977-report.pdf
- Footnote 17
-
Lambers FA, Prins M, Davidovich U, Stolte IG. High awareness of hepatitis C virus (HCV) but limited knowledge of HCV complications among HIV-positive and HIV-negative men who have sex with men. AIDS Care 2014 Apr;26(4):416–24. http://dx.doi.org/10.1080/09540121.2013.832721
- Footnote 18
-
Lea T, Hopwood M, Aggleton P. Hepatitis C knowledge among gay and other homosexually active men in Australia. Drug Alcohol Rev 2016 Jul;35(4):477–83. http://dx.doi.org/10.1111/dar.12333
- Footnote 19
-
Owiti JA, Greenhalgh T, Sweeney L, Foster GR, Bhui KS. Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review. BMC Public Health 2015 Feb;15:151. http://dx.doi.org/10.1186/s12889-015-1476-0
-
Pundhir P, North CS, Fatunde O, Jain MK. Health beliefs and co-morbidities associated with appointment-keeping behavior among HCV and HIV/HCV patients. J Community Health 2016 Feb;41(1):30–7. http://dx.doi.org/10.1007/s10900-015-0059-4
- Footnote 21
-
Rashrash ME, Maneno MK, Wutoh AK, Ettienne EB, Daftary MN. An evaluation of hepatitis C knowledge and correlations with health belief model constructs among African American “baby boomers”. J Infect Public Health 2016 Jul-Aug;9(4):436–42. http://dx.doi.org/10.1016/j.jiph.2015.11.005
- Footnote 22
-
Bianco A, Bova F, Nobile CG, Pileggi C, Pavia M; Collaborative Working Group. Healthcare workers and prevention of hepatitis C virus transmission: exploring knowledge, attitudes and evidence-based practices in hemodialysis units in Italy. BMC Infect Dis 2013 Feb;13(76):76. http://dx.doi.org/10.1186/1471-2334-13-76
- Footnote 23
-
McGowan CE, Monis A, Bacon BR, Mallolas J, Goncales FL, Goulis I, Poordad F, Afdhal N, Zeuzem S, Piratvisuth T, Marcellin P, Fried MW. A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care. Hepatology 2013 Apr;57(4):1325–32. http://dx.doi.org/10.1002/hep.26246
- Footnote 24
-
Naghdi R, Seto K, Klassen C, Emokpare D, Conway B, Kelley M, Yoshida E, Shah HA. A hepatitis C educational needs assessment of Canadian healthcare providers. Can J Gastroenterol Hepatol 2017 10:1-10. https://doi.org/10.1155/2017/5324290
- Footnote 25
-
Rotte M, O’Donnell R. Knowledge, beliefs, and attitudes of emergency department health care providers towards hepatitis C and rapid hepatitis C testing. Ann Emerg Med 2013;62(4):S103. http://dx.doi.org/10.1016/j.annemergmed.2013.07.108
- Footnote 26
-
Todorova TT, Tsankova G, Tsankova D, Kostadinova T, Lodozova N. Knowledge and attitude towards hepatitis B and hepatitis C among dental medicine students. J of IMAB 2015;21(3):810–3. http://dx.doi.org/10.5272/jimab.2015213.810
Appendix 1:
Author(s), year of publication / Country | Study design / Population / setting | Method of data collection | Outcome / Findings |
---|---|---|---|
General public (n=14) | |||
Allison et al. (2016)Footnote 8 |
Cross-sectional study |
Structured interview within six weeks of HCV antibody test to assess knowledge |
Knowledge
|
CATIE (2015)Footnote 9 |
Cross-sectional study |
Self-administered questionnaire (paper and online) |
Knowledge
|
Chen et al. (2013)Footnote 10 |
Cross-sectional study |
Cross-sectional survey and pre- and post-educational surveys |
Knowledge
|
Crutzen & Goritz (2012)Footnote 11 |
Cross-sectional study |
Two large-scale surveys administered to online panels |
Awareness
Knowledge
|
Denniston et al. (2012)Footnote 12 |
Cross-sectional study |
Phone interview |
Awareness
Knowledge
|
Eguchi & Wada (2013)Footnote 13 |
Cross-sectional study |
Self-administered questionnaire (online) |
Knowledge
|
EKOS Research Associates Inc. (2012)Footnote 14 |
Cross-sectional study |
Phone interview |
Awareness and knowledge
|
Hopwood et al. (2016)Footnote 15 |
Cross-sectional study |
Self-administered questionnaire |
Knowledge
|
Ipsos (2012)Footnote 16 |
Cross-sectional study |
Self-administered questionnaire (online) |
Knowledge
|
Lambers et al. (2013)Footnote 17 |
Observational study |
Self-administered questionnaire (paper) |
Awareness
Knowledge
|
Lea et al. (2016)Footnote 18 |
Cross-sectional study |
Self-administered questionnaire (online) |
Awareness
Knowledge
|
Owiti et al. (2015)Footnote 19 |
Systematic narrative review |
Information not available |
Knowledge
|
Pundhir et al. (2016)Footnote 20 |
Cross-sectional study |
Self-administered questionnaire (online and paper) |
Knowledge
|
Rashrash et al. (2016)Footnote 21 |
Cross-sectional study |
Cross-sectional survey using audio computer-assisted self-interviewing |
Knowledge
|
>Health care providers (n=6) | |||
Bianco et al. (2013)Footnote 22 |
Cross-sectional study |
Self-administered questionnaire |
Knowledge
|
Ipsos (2012)Footnote 16 |
Cross-sectional study |
Information not available |
Knowledge
|
McGowan et al. (2013)Footnote 23 |
Cross-sectional study |
Phone interview or self-administered online questionnaire |
Knowledge
|
Naghdi et al. (2017)Footnote 24 |
Cross-sectional study |
Self-administered questionnaire (online) |
Knowledge
|
Rotte et al. (2013)Footnote 25 |
Observational study |
Self-administered questionnaire (online) |
Knowledge
|
Todorova et al. (2015)Footnote 26 |
Cross-sectional study |
Self-administered questionnaire |
Knowledge
|
Abbreviations: CDC, Centers for Disease Control and Prevention; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; Gen, generation; GP, general practitioner; MSM, men who have sex with men; NHANES, National Health and Nutrition Examination Survey; n, number; RNA, ribonucleic acid; US, United States
|
Page details
- Date modified: